' fill='%230E4F97'%3E%3Cg id='Group-5' transform='translate(370.000000, 11.000000)'%3E%3Cg id='avatar' transform='translate(6.000000, 4.000000)'%3E%3Ccircle id='Oval' cx='8' cy='4' r='4'%3E%3C/circle%3E%3Cpath d='M7.12864205,10 L8.87135795,10 C11.558649,10 14.0087196,11.5384024 15.1762205,13.958831 L16,15.6666667 L16,15.6666667 L15.3374858,17.5134983 C15.228016,17.8186575 14.9774027,18.051811 14.6651459,18.1389975 L8,20 L8,20 L1.33485405,18.1389975 C1.02259733,18.051811 0.771984007,17.8186575 0.662514216,17.5134983 L0,15.6666667 L0,15.6666667 L0.823779545,13.958831 C1.99128041,11.5384024 4.44135104,10 7.12864205,10 Z' id='Rectangle'%3E%3C/path%3E%3C/g%3E%3C/g%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
BioNTech to build factory in Jerusalem to develop and produce vaccines
A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)
BioNTech, the German biotech company that formulated the COVID vaccine sold by Pfizer, signs a memorandum of understanding to build a new facility in Jerusalem to develop and produce vaccines.
The center, to be located in the Har Hotzvim area of the capital, will focus on mRNA technologies for medications and vaccinations to fight cancer and possible future pandemics. The agreement also gives Israel the ability to be the first to purchase vaccines in the case of a pandemic outbreak.
A representative of BioNTech signs the memorandum in the capital with Jerusalem Mayor Moshe Lion, as well as Health and Finance ministry officials.
